[go: up one dir, main page]

AU2002246757B2 - Methods and compositions for treating periodontal disease - Google Patents

Methods and compositions for treating periodontal disease Download PDF

Info

Publication number
AU2002246757B2
AU2002246757B2 AU2002246757A AU2002246757A AU2002246757B2 AU 2002246757 B2 AU2002246757 B2 AU 2002246757B2 AU 2002246757 A AU2002246757 A AU 2002246757A AU 2002246757 A AU2002246757 A AU 2002246757A AU 2002246757 B2 AU2002246757 B2 AU 2002246757B2
Authority
AU
Australia
Prior art keywords
phenyl
cox
methyl
inhibitor
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002246757A
Other languages
English (en)
Other versions
AU2002246757A1 (en
Inventor
George D. Hartman
Gideon A. Rodan
Sevgi B. Rodan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU2002246757A1 publication Critical patent/AU2002246757A1/en
Application granted granted Critical
Publication of AU2002246757B2 publication Critical patent/AU2002246757B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Furan Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2002246757A 2001-01-03 2001-12-28 Methods and compositions for treating periodontal disease Ceased AU2002246757B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25944101P 2001-01-03 2001-01-03
US60/259,441 2001-01-03
PCT/US2001/049638 WO2002053099A2 (fr) 2001-01-03 2001-12-28 Methodes et compositions de traitement d'une parodontopathie

Publications (2)

Publication Number Publication Date
AU2002246757A1 AU2002246757A1 (en) 2003-01-23
AU2002246757B2 true AU2002246757B2 (en) 2006-02-02

Family

ID=22984959

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002246757A Ceased AU2002246757B2 (en) 2001-01-03 2001-12-28 Methods and compositions for treating periodontal disease

Country Status (5)

Country Link
EP (1) EP1349548A4 (fr)
JP (1) JP2004517853A (fr)
AU (1) AU2002246757B2 (fr)
CA (1) CA2432504A1 (fr)
WO (1) WO2002053099A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201305668D0 (en) 2013-03-28 2013-05-15 Glaxosmithkline Ip Dev Ltd Avs6 Integrin Antagonists
HUE063437T2 (hu) 2013-09-24 2024-01-28 Fujifilm Corp Nitrogént tartalmazó vegyületet vagy sóját vagy fémkomplexét tartalmazó gyógyászati készítmény
GB201417011D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201417002D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compound
GB201417094D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201417018D0 (en) 2014-09-26 2014-11-12 Glaxosmithkline Ip Dev Ltd Novel compounds
GB201604680D0 (en) 2016-03-21 2016-05-04 Glaxosmithkline Ip Dev Ltd Chemical Compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
US20020028798A1 (en) * 1995-12-12 2002-03-07 Omeros Medical Systems Irrigation solution and method for inhibition of pain and inflammation
US6017926A (en) * 1997-12-17 2000-01-25 Merck & Co., Inc. Integrin receptor antagonists
KR20030048081A (ko) * 1997-12-17 2003-06-18 머크 앤드 캄파니 인코포레이티드 인테그린 수용체 길항제를 포함하는 약제학적 조성물
US6048861A (en) * 1997-12-17 2000-04-11 Merck & Co., Inc. Integrin receptor antagonists
US6136804A (en) * 1998-03-13 2000-10-24 Merck & Co., Inc. Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions
AU747784B2 (en) * 1998-07-29 2002-05-23 Merck & Co., Inc. Integrin receptor antagonists
IL146378A0 (en) * 1999-06-02 2002-07-25 Merck & Co Inc Alpha v integrin receptor antagonists

Also Published As

Publication number Publication date
WO2002053099A3 (fr) 2002-09-12
CA2432504A1 (fr) 2002-07-11
WO2002053099A2 (fr) 2002-07-11
EP1349548A4 (fr) 2004-06-02
EP1349548A2 (fr) 2003-10-08
JP2004517853A (ja) 2004-06-17

Similar Documents

Publication Publication Date Title
ES2234324T3 (es) Combinaciones de un agonista 5ht1b/1d y un inhibidor selectivo de cox-2 para el tratamiento de la migraña.
CA2328730C (fr) Traitement de l'hypertension iatrogene et liee au vieillissement et compositions pharmaceutiques utiles a cet effet
US6232315B1 (en) Method for treating inflammatory diseases by administering a thrombin inhibitor
KR100671392B1 (ko) 항균제로서의 화합물의 신규한 용도
NO321388B1 (no) Farmasoytisk sammensetning inneholdende en forbindelse med angiotensin II antagonistisk aktivitet i kombinasjon med en forbindelse som har insulinsensitivitetsstimulerende aktivitet, og anvendelse av samme for fremstilling av medikament.
ZA200110349B (en) Combination of tumors necrocis factor (TNF) antagonists and cox-2 inhibitors for the treatment of inflammation.
AU2002246757B2 (en) Methods and compositions for treating periodontal disease
US20040053968A1 (en) Methods and compositions for treating peridontal disease
US20020040039A1 (en) Treatment of inflammation with a combination of a cyclooxygenase-2 inhibitor and an integrin alpha-v antagonist
AU2002246757A1 (en) Methods and compositions for treating periodontal disease
US20040186155A1 (en) Combination therapy for the treatment or prevention of migraine
KR20020075797A (ko) 엔도텔린 유발성 질환 치료제
US7358254B2 (en) Method for treating atherosclerosis employing an aP2 inhibitor and combination
JPH0489428A (ja) 多形核白血球活性化剤
JP2006096665A (ja) 脊柱管狭窄症治療剤
RU2336872C2 (ru) Аннелированные пиррольные соединения как ингибиторы протонового насоса для лечения язвы
AU758983B2 (en) Use of a COX-2 inhibitor and a NK-1 receptor antagonist for treating inflammation
JP6824015B2 (ja) 歯槽骨吸収抑制剤
IL95880A (en) Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis
JP4677705B2 (ja) 頭痛の予防および／または治療剤
EP0338010A1 (fr) Compositions pharmaceutiques pour le traitement des maladies de la peau hyperproliferantes.

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired